FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1830885 · Received September 8, 2010

Report

Report Number
2024168-2010-01874
Event Type
Injury
Date Received
September 8, 2010
Date of Event
April 17, 2010
Report Date
July 28, 2010
Manufacturer
ABBOTT VASCULAR CLONMEL
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PT EFFECTS OF ANGINA AND RESTENOSIS, AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE (IFU), ARE KNOWN ADVERSE EVENTS ASSOCIATED WITH CORONARY STENTING PROCEDURES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MFR, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED VIA TRIAL, THAT APPROX 6 MONTHS POST A MID-LEFT ANTERIOR DESCENDING (LAD) ARTERY STENTING PROCEDURE WITH A XIENCE V STENT, THE PT EXPERIENCED A SELF LIMITING EPISODE OF ANGINA WITH SOME SHORTNESS OF BREATH. A NUCLEAR STRESS TEST WAS NEGATIVE. ON (B)(6) 2010, THE PT WAS ADMITTED FOR A CARDIAC CATHETERIZATION. IN-STENT RESTENOSIS AND NEW LESIONS WERE FOUND. BALLOON ANGIOPLASTY AND TWO ADDITIONAL XIENCE STENTS WERE PLACED IN THE MID AND PROXIMAL LAD. THERE WAS NO ADVERSE PT SEQUELA REPORTED. ON (B)(6) 2010, THE PT WAS DISCHARGED TO HOME. ALTHOUGH REQUESTED, THERE WAS NO ADDITIONAL INFO PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR CLONMEL NA 9080641

Patients

Seq Age Sex Outcome Treatment
1 76 YR Hospitalization| R